Eyexora is a company headquartered in the United States. Its most recent tracked round is Seed.
Eyexora is a global ophthalmology company that accelerates the development of eye care therapies and devices using a centralized hub-and-spoke model, managing multiple programs in parallel including retina, anterior segment diseases, and cell therapy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.